Correlation between the dexamethasone suppression test in depressed patients and clinical response

Am J Psychiatry. 1984 Feb;141(2):247-9. doi: 10.1176/ajp.141.2.247.

Abstract

Eighteen psychiatric inpatients who fulfilled DSM-III criteria for major depression and who had a positive dexamethasone suppression test after admission were later retested. Of the 13 patients who exhibited cortisol suppression at discharge, two relapsed within 6 months; five remained nonsuppressors at discharge, and all either required further inpatient care or were symptomatic within 2 weeks to 4 months. Continued cortisol nonsuppression was thus associated with poor clinical response or high risk of relapse.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder / blood
  • Depressive Disorder / diagnosis*
  • Depressive Disorder / therapy
  • Dexamethasone*
  • Electroconvulsive Therapy
  • Female
  • Follow-Up Studies
  • Hospitalization
  • Humans
  • Hydrocortisone / blood
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Recurrence

Substances

  • Antidepressive Agents
  • Dexamethasone
  • Hydrocortisone